About
Chemistry professor at Columbia University with research background in synthetic and medicinal chemistry, molecular imaging, and neuropharmacology. His work has included research on C-H bond functionalization methods, fluorescent probes for synaptic imaging, and the pharmacology of various natural alkaloids.
Founder at Gilgamesh PharmaceuticalsYC S20
Intro paths
YC
Dalibor went through Y Combinator (Summer 2020) — any YC alum in your network can reach them through the YC community.
GP
Their group partner at YC was Jared Friedman, General Partner at Y Combinator — the partner who ran Gilgamesh Pharmaceuticals's batch and knows the company first-hand. YC profile ↗
→
In turn, Dalibor can intro founders to Gilgamesh Pharmaceuticals's investors below.
Gilgamesh Pharmaceuticals's investors · 10
Co-founders at Gilgamesh Pharmaceuticals
JS
Jonathan SpornFounder
AK
Andrew KruegelFounder
JS
JONATHAN SPORNFounder
TK
Thomas Kevin Murphy, Ph.D.Executive Officer
AK
Andrew Kruegel, Ph.D.Executive Officer
JS
Jonathan Sporn, M.D.President and Chief Executive Officer